Sleep Medicine & Neurology
Sleep Disorders Clinical Research
Millions of people across the U.S. struggle with sleep disorders that impact physical health, mental well-being, and daily performance. CenExel partners with sponsors to advance innovative sleep medicine treatments through specialized research, experienced investigators, and diverse patient populations.
Advancing Research in Sleep Disorders
CenExel provides comprehensive clinical research support for sleep-related disorders through experienced investigators, specialized sleep medicine teams, and advanced operational capabilities. Our sites support studies ranging from insomnia and circadian rhythm disorders to narcolepsy and sleep apnea.
Specialized Sleep Research Teams
Faster Study Enrollment
Sleep Disorders We Research
Our sleep medicine research sites support a broad range of sleep-related disorders and neurological conditions.
- Insomnia Disorder
- Obstructive Sleep Apnea (OSA)
- Narcolepsy
- Restless Legs Syndrome (RLS)
- Circadian Rhythm Disorders
- Excessive Daytime Sleepiness
- Shift Work Sleep Disorder
- REM Sleep Behavior Disorder
Why Sponsors Choose CenExel for Sleep Research
Our sleep medicine research teams provide scientific guidance, operational excellence, and access to specialized patient populations to support successful trial execution.
01
Sleep Medicine Expertise
Experienced investigators specializing in insomnia, narcolepsy, circadian rhythm disorders, and sleep apnea research.
02
Advanced Biomarker Strategy
Support for sleep monitoring technologies, wearable devices, EEG-based assessments, and patient-reported outcomes.
03
Diverse Patient Access
Broad recruitment networks across multiple research sites improve enrollment speed and demographic diversity.
04
High-Quality Trial Execution
CenExel sites consistently support rapid startup timelines, high-quality data collection, and strong participant retention.
Supported Sleep Research Trial Phases
CenExel supports early and late-phase sleep disorder studies — from first-in-human trials through Phase IV post-market research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our teams support insomnia therapies, sleep apnea devices, CNS-focused compounds, and digital sleep monitoring technologies with high-quality operational support.
Sleep Disorders Task Force
CenExel supports sponsors developing innovative therapies for sleep-related disorders, neurological conditions, and behavioral health indications across adult and pediatric populations.






